These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37256962)

  • 1. Aryl hydrocarbon receptor is a proviral host factor and a candidate pan-SARS-CoV-2 therapeutic target.
    Shi J; Du T; Wang J; Tang C; Lei M; Yu W; Yang Y; Ma Y; Huang P; Chen H; Wang X; Sun J; Wang H; Zhang Y; Luo F; Huang Q; Li B; Lu S; Hu Y; Peng X
    Sci Adv; 2023 Jun; 9(22):eadf0211. PubMed ID: 37256962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine Coronavirus Activates Aryl Hydrocarbon Receptor during In Vitro Infection.
    Cerracchio C; Serra F; Amoroso MG; Fiorito F
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AHR signaling is induced by infection with coronaviruses.
    Giovannoni F; Li Z; Remes-Lenicov F; Dávola ME; Elizalde M; Paletta A; Ashkar AA; Mossman KL; Dugour AV; Figueroa JM; Barquero AA; Ceballos A; Garcia CC; Quintana FJ
    Nat Commun; 2021 Aug; 12(1):5148. PubMed ID: 34446714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine Coronavirus Infection Activates the Aryl Hydrocarbon Receptor in an Indoleamine 2,3-Dioxygenase-Independent Manner, Contributing to Cytokine Modulation and Proviral TCDD-Inducible-PARP Expression.
    Grunewald ME; Shaban MG; Mackin SR; Fehr AR; Perlman S
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan Metabolites and Aryl Hydrocarbon Receptor in Severe Acute Respiratory Syndrome, Coronavirus-2 (SARS-CoV-2) Pathophysiology.
    Anderson G; Carbone A; Mazzoccoli G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction.
    Biagioli M; Marchianò S; Roselli R; Di Giorgio C; Bellini R; Bordoni M; Gidari A; Sabbatini S; Francisci D; Fiorillo B; Catalanotti B; Distrutti E; Carino A; Zampella A; Costantino G; Fiorucci S
    Biochem Pharmacol; 2021 Jun; 188():114564. PubMed ID: 33872570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target.
    Giovannoni F; Quintana FJ
    Cell Res; 2021 Jan; 31(1):1-2. PubMed ID: 33262451
    [No Abstract]   [Full Text] [Related]  

  • 8. Cigarette Smoke Stimulates SARS-CoV-2 Internalization by Activating AhR and Increasing ACE2 Expression in Human Gingival Epithelial Cells.
    Almeida-da-Silva CLC; Matshik Dakafay H; Liu K; Ojcius DM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothesis: Emerging Roles for Aryl Hydrocarbon Receptor in Orchestrating CoV-2-Related Inflammation.
    Guarnieri T
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting SARS-CoV-2 infection in vitro by suppressing its receptor, angiotensin-converting enzyme 2, via aryl-hydrocarbon receptor signal.
    Tanimoto K; Hirota K; Fukazawa T; Matsuo Y; Nomura T; Tanuza N; Hirohashi N; Bono H; Sakaguchi T
    Sci Rep; 2021 Aug; 11(1):16629. PubMed ID: 34404832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of environmental pollution on immune evasion checkpoints of SARS-CoV-2.
    Engin AB; Engin ED; Engin A
    Environ Toxicol Pharmacol; 2021 Jan; 81():103520. PubMed ID: 33132153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 Infection.
    Rocha SM; Fagre AC; Latham AS; Cummings JE; Aboellail TA; Reigan P; Aldaz DA; McDermott CP; Popichak KA; Kading RC; Schountz T; Theise ND; Slayden RA; Tjalkens RB
    Front Immunol; 2022; 13():811430. PubMed ID: 35250984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AhR and IDO1 in pathogenesis of Covid-19 and the "Systemic AhR Activation Syndrome:" a translational review and therapeutic perspectives.
    Turski WA; Wnorowski A; Turski GN; Turski CA; Turski L
    Restor Neurol Neurosci; 2020; 38(4):343-354. PubMed ID: 32597823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics.
    Pérez-Vargas J; Shapira T; Olmstead AD; Villanueva I; Thompson CAH; Ennis S; Gao G; De Guzman J; Williams DE; Wang M; Chin A; Bautista-Sánchez D; Agafitei O; Levett P; Xie X; Nuzzo G; Freire VF; Quintana-Bulla JI; Bernardi DI; Gubiani JR; Suthiphasilp V; Raksat A; Meesakul P; Polbuppha I; Cheenpracha S; Jaidee W; Kanokmedhakul K; Yenjai C; Chaiyosang B; Teles HL; Manzo E; Fontana A; Leduc R; Boudreault PL; Berlinck RGS; Laphookhieo S; Kanokmedhakul S; Tietjen I; Cherkasov A; Krajden M; Nabi IR; Niikura M; Shi PY; Andersen RJ; Jean F
    Antiviral Res; 2023 Jan; 209():105484. PubMed ID: 36503013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion.
    Ho HPT; Vo DNK; Lin TY; Hung JN; Chiu YH; Tsai MH
    Biomed Pharmacother; 2022 Nov; 155():113766. PubMed ID: 36271550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abiotic Synthetic Antibody Inhibitor with Broad-Spectrum Neutralization and Antiviral Efficacy against Escaping SARS-CoV-2 Variants.
    Li B; Zhao Y; Wu X; Wu H; Tang W; Yu X; Mou J; Tan W; Jin M; Li W; Zhang Q; Liu M
    ACS Nano; 2023 Apr; 17(7):7017-7034. PubMed ID: 36971310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AHR is a Zika virus host factor and a candidate target for antiviral therapy.
    Giovannoni F; Bosch I; Polonio CM; Torti MF; Wheeler MA; Li Z; Romorini L; Rodriguez Varela MS; Rothhammer V; Barroso A; Tjon EC; Sanmarco LM; Takenaka MC; Modaresi SMS; Gutiérrez-Vázquez C; Zanluqui NG; Dos Santos NB; Munhoz CD; Wang Z; Damonte EB; Sherr D; Gehrke L; Peron JPS; Garcia CC; Quintana FJ
    Nat Neurosci; 2020 Aug; 23(8):939-951. PubMed ID: 32690969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl Hydrocarbon Receptor Activation Ameliorates Acute Respiratory Distress Syndrome through Regulation of Th17 and Th22 Cells in the Lungs.
    Holloman BL; Cannon A; Wilson K; Nagarkatti P; Nagarkatti M
    mBio; 2023 Apr; 14(2):e0313722. PubMed ID: 36809070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.